Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Argus Health
UBS
Moodys
US Department of Justice
Chinese Patent Office
Medtronic
Chubb

Generated: April 19, 2018

DrugPatentWatch Database Preview

Sincalide - Generic Drug Details

« Back to Dashboard

What are the generic sources for sincalide and what is the scope of sincalide freedom to operate?

Sincalide
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sincalide has ten patent family members in eight countries.

There are two drug master file entries for sincalide. One supplier is listed for this compound.
Summary for sincalide
International Patents:10
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Suppliers / Packagers: 1
Bulk Api Vendors: 22
Clinical Trials: 3
Patent Applications: 477
Drug Prices:see low prices
DailyMed Link:sincalide at DailyMed
Pharmacology for sincalide
Ingredient-typeCholecystokinin
Drug ClassCholecystokinin Analog
Synonyms for sincalide
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,2
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S
(3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]
(3S)-3-azanyl-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide
[125I]CCK-8
1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein
126S323
25126-32-3
25345-10-2
89911-55-7
9038-72-6
91921-74-3
A817659
AKOS016340423
BDBM21147
C49H62N10O16S3
Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-
CAS-25126-32-3
CCK C-terminal octapeptide
CCK Octapeptide, sulfated
CCK-8
CCK-8 (sulphated)
CCK-8(SO3)
CHEBI:135946
CHEMBL1121
cholecystokinin 8
cholecystokinin C-terminal octapeptide
cholecystokinin fragment 26-33 amide (sulphated)
Cholecystokinin octapeptide
Cholecystokinin Octapeptide, sulfated
Cholecystokinin-8
Cholecystokinin-pancreozymin
CS-5963
D05845
D0I8AF
DB09142
DSSTox_CID_28543
DSSTox_GSID_48617
DSSTox_RID_82815
DTXSID7048617
EINECS 246-639-0
FT-0630515
GTPL864
H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
Human CCK-8
HY-P0093
IZTQOLKUZKXIRV-YRVFCXMDSA-N
Kinevac
Kinevac (TN)
L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester)
M03GIQ7Z6P
MFCD00079849
MolPort-006-124-517
NCGC00167273-01
NCGC00183278-01
NCGC00183363-01
O411
Pancreozymin
Pancreozymin C-terminal octapeptide
SC-47569
SCHEMBL122365
Sincalida
Sincalida [INN-Spanish]
Sincalide (Kinevac)
Sincalide (USP/INN)
Sincalide [USAN:USP:INN:BAN]
Sincalidum
Sincalidum [INN-Latin]
SQ 19844
SQ-19844
Syncalide
Tox21_112955
Tox21_113481
UNII-M03GIQ7Z6P

US Patents and Regulatory Information for sincalide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco KINEVAC sincalide INJECTABLE;INJECTION 017697-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Cerilliant
Harvard Business School
UBS
Deloitte
Merck
Cantor Fitzgerald
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.